Molecular Diagnosis & Therapy
Springer International Publishing · New Zealand
Metrics
- Impact factor
- 5.8+1.4 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.812Q1 SCImago
- h-index
- 34
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 5.69 last 2 years
- Articles per year
- 60
- Self-citation
- 2.4%
- Fee (APC), est.
- $3,512 estimated, check the journal
About this journal
- ISSN
- 1177-1062 (print) · 1179-2000 (online)
- Publisher
- Springer International Publishing · Springer Nature
- Country
- New Zealand · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 40.2% gold OA
- Founded
- 2000
- Frequency
- Bimonthly
- Original research
- 66.1%
- Subject areas
- Biochemistry, Genetics and Molecular Biology, Medicine, Pharmacology, Toxicology and Pharmaceutics
- Categories
- Medicine, Pharmacy
- Common topics
- Biology, Medicine, Genetics, Chemistry, Biochemistry
Similar journals
- Q1WoS
Cell
Impact factor 45.1h-index 705SJR 24.59 - Q1WoS
Journal of the American Chemical Society
Impact factor 16.6h-index 542SJR 5.49 - Q1WoS
Nature Genetics
Impact factor 25.5h-index 527SJR 15.38 - Q1WoS
Nature Medicine
Impact factor 52.5h-index 497SJR 17.50 - Q1WoS
Journal of Clinical Oncology
Impact factor 44.7h-index 494SJR 4.65 - Q1WoS
Nucleic Acids Research
Impact factor 15h-index 452SJR 8.11
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals